ale for explaining these phenomena. I would like to review the picture of rheumatic fever as it has emerged in studies we have carried out in Baltimore over a period of more than two decades. I shall then try to place the changes that have occurred in the context of other diseases that have either increased or decreased in incidence or mortality in the United States during the 20th century.
The Baltimore studies. The earliest of these studies were carried out in collaboration with Dr. Milton Markowitz. In the ensuing years he has continued to be a stimulus and constructive critic and is, in essence, a spiritual collaborator in all these investigations. Our first study in Baltimore examined the incidence patterns of acute rheumatic fever from 1960 to 1964.2 The findings were marked by dramatic racial differences. Rates of both initial and recurrent attacks were more than twice as frequent in blacks as in whites. These findings were consistent with the observation that the disease tended to cluster in the predominantly black areas of the inner city of Baltimore. Relatively few of the cases occurred in suburban areas.
In a second study we found that from 1960-64 to 1968-70, the rates in blacks in Baltimore dropped dramatically while the rates in whites remained relatively unchanged. To explain this change we asked the question: Could the decline in incidence in black children be due to the inner city comprehensive care programs for children and youth that had been established in the mid-1960s? A study was therefore carried out to compare the incidence of rheumatic fever in census tracts eligible for comprehensive care compared to census tracts not eligible for comprehensive care.' As seen in figure 1 , in the census tracts that were eligible for comprehensive care, incidence of rheumatic fever dropped 60% from 1960-64 to 1968-70. In yngitis. Thus the data up to 1970 were highly consistent with the hypothesis that in Baltimore, the decline in rheumatic fever, which was limited to blacks, was primarily a result of the comprehensive care programs in the inner city.
More recently, we carried out a third study in Baltimore utilizing the same methods as the two previous investigations. As seen in figure 3 , from 1968-70 to 1977-81, incidence rates of rheumatic fever dropped dramatically in both whites and blacks to extremely low rates. Perhaps the most dramatic view of these changes is seen in figure 4 , which shows spot maps for rheumatic fever cases for the first and last 5 year periods of this study, 1960-64 on the left and 1977-81 on the right. Only five cases were seen in Baltimore from 1977 to 1981, and all were clinically mild.
National data for the United States. These findings are consistent with data reported from other communities, such as those of Land and Bisno from Memphis, Tennessee. 4 Available evidence suggests that this is also the pattern in other cities in the United States in most populations. National data for hospital discharges with a diagnosis of rheumatic fever from the National Hospital Discharge Survey conducted by the National Center for Health Statistics, and kindly provided by Dr. Edward Bacon of the Center, confirm this decline (table 1). The decline is also seen when the rates are If the incidence of streptococcal infections has in fact declined, the decline could be part of a cyclical pattern of increases and decreases in incidence of streptococcal infections and that we may just be on the down side of the curve at this point in time. If indeed there is such a cyclic phenomenon, we might anticipate another rise in streptococcal incidence in the future and with it a possible rise in rheumatic fever incidence.
Could there have been a change in the prevalence of rheumatogenic types in our communities or in the incidence of infections produced by rheumatogenic types? Although there is strong evidence that there are nephritogenic types, the case for rheumatogenic types is not clear. Support for this contention comes from several types of evidence: (1) The temporal and geographic variations observed in rheumatic fever incidence are consistent with the existence of rheumatogenic and nonrheumatogenic types. (2) Early data from Kuttner and Krumweidef suggested differences in rheumatic fever attack rates depending on the serologic type of streptococcus in the outbreak. (3) Data from Potter et al. 7 suggest that in Trinidad the serologic types of streptococci causing rheumatic fever differ from those causing nephritis even in the same families. (4) Seasonal differences reported in occurrence of rheumatic fever and of glomerulonephritis are also consistent with different rheumatogenic potential of different serotypes.8 (5) Rheumatic fever and nephritis rarely occur simultaneously.
Could there have been a change in the virulence of the streptococcus over time? This is certainly a possibility, although as McCarty has suggested, given the fact that no single serologic type has been demonstrated to be rheumatogenic, any changes in virulence would have had to occur in several serologic types of streptococci simultaneously.9 Nevertheless, we do see some evidence consistent with changes in the virulence of the streptococcus. Scarlet fever has become a much milder disease over the last few decades and its incidence has perhaps declined. Data from Baltimore suggest that the incidence of poststreptococcal acute glomerulonephritis may also have declined, although not as markedly as that of rheumatic fever (figure 5). Further evidence consistent with a possible change in virulence of the organism is the changing pattern of antibiotic sensitivity of the streptococcus. High rates of resistance of streptococci to tetracycline, and to a lesser extent to erythromycin and lincomycin, have been reported.'0 There is some ambiguity associated with the term "virulence." Virulence may refer to the capacity of the streptococcus to adhere to human epithelium, to its ability to evoke an antibody response, to its ability to produce clincial pharyngitis or other infection, or to its rheumatogenic or nephritogenic potential. Streptococcal virulence has been associated with the M protein of the cell surface, which has antiphagocytic properties and may also enhance the adherence of the streptococcus to epithelial cells by forming a complex with lipoteichoic acid. It is important to note that host factors have long been recognized as playing a role in the risk of rheumatic fever. The higher risk of rheumatic fever in children has generally been attributed to their greater exposure to streptococcal infections. However, it has been reported that streptococci adhere more vigorously to cells from young compared with middle-aged subjects. 17 This suggests the possibility that endocrine factors, for example, may affect infectivity and rheumatogenicity. Examples from other diseases support the notion that such host factors above and beyond any genetically determined susceptibility may play a role. For example, it is well recognized that pregnancy places a woman at increased risk of acquiring poliomyelitis. Particularly in the prevaccine era, it was also recognized that tonsillectomy increased the risk for bulbar poliomyelitis.
It is interesting to reflect on the reasons we have so much difficulty today in explaining the marked decline in the incidence of rheumatic fever. One aspect of this problem specifically merits discussion because it may have implications for our approaches to the etiologies of other diseases in the future. After Lancefield pub-1160 lished her landmark work on the streptococcus, investigators interested in rheumatic fever quite appropriately focused their attention on confirming the relationship between the streptococcus and rheumatic fever and on elucidating the pathogenetic pathways involved. As the streptococcus was pursued, the possible etiologic role of factors other than the streptococcus in rheumatic fever received relatively little attention. That such factors genetic, environmental, or a combination thereof are in fact probably playing .~~~~~~~Z OUU0r such a role is suggested by the data from the studies that yielded estimated rheumatic fever attack rates of 3% in the military and of 0.3% in civilian populations of children. Thus 97 of every 100 recruits who acquired a streptococcal infection did not develop rheumatic fever and 997 of every 1000 children who acquired streptococcal infections did not develop rheumatic fever. Why not? What factors could account for the small percentage of individuals with streptococcal sore throats who subsequently developed rheumatic fever, even in days when rheumatic fever was more common in the United States? In this context, it is worthwhile to look at the approaches taken by epidemiologists to study the etiology of chronic diseases today, particularly when it is desired to explore the possible role of a number of etiologic agents. The approach often used initially is the case-control study (figure 8). In this design, patients with the disease ("cases") are compared with control subjects without the disease and the proportions of cases and controls with specific characteristics or exposures are compared. In the case of rheumatic fever, in which the streptococcus had been clearly implicated, case-control studies addressing genetic and environmental factors other than the streptococcus would have been very valuable. Thus a study of viral factors in rheumatic fever in association with streptococcal infections could be carried out would suggest that other host and environmental characteristics should also be considered. The relative lack of rigorously designed and conducted case-control studies in the search for a full understanding of the etiology of rheumatic fever is understandable, since much of Lancefield's work was published at a time when the case-control design had not yet received full recognition and acceptability and was ony sporadically used. Not until the 1950s, when the case-control study design played a major role in establishing the relationship between cigarette smoking and lung cancer, was the case-control study fully legitimized. By this time the streptococcus was viewed as the full solution to the etiology of rheumatic fever, and as a result, a diligent search for other variables that might be involved was never carried out. Thus rheumatic fever began its dramatic decline in the United States before adequate attempts had been made to investigate the role of other etiologic agents above and beyond the streptococcus. Consequently, in the absence of a full understanding of the etiology of rheumatic fever today, we are unable to definitively explain its decline.
Rheumatic fever in the third world. Although the risk of rheumatic fever has been sharply declining in the United States, the picture is far different in developing countries. Worldwide, rheumatic heart disease remains the most common form of acquired heart disease in children and young adults and an important cause of all heart disease seen in adults. The status of rheumatic fever and rheumatic heart disease in developing countries has been succinctly summarized by Markowitz2l: (1) Rheumatic fever is the most frequent cause of heart disease in the 5 to 30 year age group. (2) Acute rheumatic fever and rheumatic heart disease are two of the most common causes of death in young people. (3) Rheumatic heart disease causes 25% to 40% of all cardiovascular disease. Estimated prevalence of rheumatic heart disease in India schoolchildren is six to 11 per 1000.22 Thirty-three to fifty percent of all hospital admissions for heart disease are for rheumatic heart disease.
Even Conclusion. In conclusion, although the group A streptococcus is the critical etiologic agent of rheumatic fever, the disease may well be multifactorial in origin. While improved medical care and the use of penicillin and other antibiotics have contributed significantly to the decline of rheumatic fever in the United States, the decline antedated the availability of antibiotics, and in addition the changes in rheumatic fever in the United States cannot be fully accounted for solely by medical care and antibiotic use. The difficulty is that we lack adequate information regarding other possible cofactors. Studies of such factors are not feasible in the United States today in view of the very low incidence of the disease, but such etiologic investigations could be initiated and conducted in developing countries.
From the clinical standpoint, the low risk of rheumatic fever today suggests that perhaps we should reassess present policies regarding our hunt for the streptococcus and our determination to eradicate it. However, any relaxation of our currently recommended approaches to streptococcal infections should be undertaken with great caution, since we do not understand the reasons for the decline and consequently cannot fully anticipate the possible results of any relaxation in policy. In any case, such a relaxation would be highly inappropriate for developing countries in which the risks of rheumatic fever and rheumatic heart disease remain so high.
Finally, there is an urgent need for additional research both on the biology of the streptococcus and the pathogenetic mechanisms involved in the development of rheumatic fever as well as on other factors that may interact with the streptococcus and influence the risk of disease. Such research may not only be valuable in improving the health of populations that are at high risk for rheumatic fever in developing countries, but may also shed light on the pathogenesis of other nonsuppurative sequelae of infectious diseases.
